CN104432099B - Health food containing vitamin K2 - Google Patents
Health food containing vitamin K2 Download PDFInfo
- Publication number
- CN104432099B CN104432099B CN201410801527.4A CN201410801527A CN104432099B CN 104432099 B CN104432099 B CN 104432099B CN 201410801527 A CN201410801527 A CN 201410801527A CN 104432099 B CN104432099 B CN 104432099B
- Authority
- CN
- China
- Prior art keywords
- calcium
- vitamin
- weight
- percentage
- health food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013402 health food Nutrition 0.000 title abstract description 9
- PFRQBZFETXBLTP-UHFFFAOYSA-N Vitamin K2 Natural products C1=CC=C2C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-UHFFFAOYSA-N 0.000 title abstract 5
- DKHGMERMDICWDU-GHDNBGIDSA-N menaquinone-4 Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 DKHGMERMDICWDU-GHDNBGIDSA-N 0.000 title abstract 5
- 235000019143 vitamin K2 Nutrition 0.000 title abstract 5
- 239000011728 vitamin K2 Substances 0.000 title abstract 5
- 229940088594 vitamin Drugs 0.000 claims abstract description 48
- 235000013343 vitamin Nutrition 0.000 claims abstract description 48
- 239000011782 vitamin Substances 0.000 claims abstract description 48
- 229930003231 vitamin Natural products 0.000 claims abstract description 48
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 48
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract description 29
- 235000013305 food Nutrition 0.000 claims abstract description 25
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 21
- 239000011707 mineral Substances 0.000 claims abstract description 21
- 239000006041 probiotic Substances 0.000 claims abstract description 18
- 235000018291 probiotics Nutrition 0.000 claims abstract description 18
- 108010001441 Phosphopeptides Proteins 0.000 claims abstract description 16
- 229960002685 biotin Drugs 0.000 claims abstract description 15
- 235000020958 biotin Nutrition 0.000 claims abstract description 15
- 239000011616 biotin Substances 0.000 claims abstract description 15
- 239000000284 extract Substances 0.000 claims abstract description 14
- 150000003839 salts Chemical class 0.000 claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 12
- 235000013336 milk Nutrition 0.000 claims abstract description 4
- 239000008267 milk Substances 0.000 claims abstract description 4
- 210000004080 milk Anatomy 0.000 claims abstract description 4
- 241000894006 Bacteria Species 0.000 claims description 18
- 230000000529 probiotic effect Effects 0.000 claims description 16
- 102000004407 Lactalbumin Human genes 0.000 claims description 15
- 108090000942 Lactalbumin Proteins 0.000 claims description 15
- 239000002671 adjuvant Substances 0.000 claims description 15
- 229940071162 caseinate Drugs 0.000 claims description 15
- 229920002472 Starch Polymers 0.000 claims description 13
- 235000019698 starch Nutrition 0.000 claims description 13
- 239000008107 starch Substances 0.000 claims description 13
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 11
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 11
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 11
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 11
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 6
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 6
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 4
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 4
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 235000010980 cellulose Nutrition 0.000 claims description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims 1
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims 1
- 102000002322 Egg Proteins Human genes 0.000 claims 1
- 108010000912 Egg Proteins Proteins 0.000 claims 1
- 229910000004 White lead Inorganic materials 0.000 claims 1
- 229940009289 bifidobacterium lactis Drugs 0.000 claims 1
- 235000014103 egg white Nutrition 0.000 claims 1
- 210000000969 egg white Anatomy 0.000 claims 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 78
- 239000011575 calcium Substances 0.000 abstract description 78
- 229910052791 calcium Inorganic materials 0.000 abstract description 78
- 210000004369 blood Anatomy 0.000 abstract description 20
- 239000008280 blood Substances 0.000 abstract description 20
- 239000000203 mixture Substances 0.000 abstract description 15
- 239000000463 material Substances 0.000 abstract description 8
- 235000018102 proteins Nutrition 0.000 abstract description 7
- 102000004169 proteins and genes Human genes 0.000 abstract description 7
- 108090000623 proteins and genes Proteins 0.000 abstract description 7
- 230000009471 action Effects 0.000 abstract description 3
- 239000005018 casein Substances 0.000 abstract description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract description 2
- 235000021240 caseins Nutrition 0.000 abstract description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 2
- 241000219780 Pueraria Species 0.000 abstract 1
- 108010046377 Whey Proteins Proteins 0.000 abstract 1
- 102000007544 Whey Proteins Human genes 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 235000021119 whey protein Nutrition 0.000 abstract 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 34
- 235000010755 mineral Nutrition 0.000 description 18
- 229910000019 calcium carbonate Inorganic materials 0.000 description 17
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 16
- 239000002775 capsule Substances 0.000 description 16
- 239000011574 phosphorus Substances 0.000 description 16
- 229910052698 phosphorus Inorganic materials 0.000 description 16
- 210000000689 upper leg Anatomy 0.000 description 16
- 230000000968 intestinal effect Effects 0.000 description 15
- 210000000988 bone and bone Anatomy 0.000 description 14
- 238000010521 absorption reaction Methods 0.000 description 13
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 12
- 230000037182 bone density Effects 0.000 description 12
- 230000000694 effects Effects 0.000 description 10
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- 235000015097 nutrients Nutrition 0.000 description 8
- 230000006870 function Effects 0.000 description 7
- 208000001132 Osteoporosis Diseases 0.000 description 6
- 208000022458 calcium metabolism disease Diseases 0.000 description 6
- 230000037118 bone strength Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 229940046010 vitamin k Drugs 0.000 description 5
- 241000186016 Bifidobacterium bifidum Species 0.000 description 4
- 206010005963 Bone formation increased Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 235000006408 oxalic acid Nutrition 0.000 description 4
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 3
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000003913 calcium metabolism Effects 0.000 description 3
- MWKXCSMICWVRGW-UHFFFAOYSA-N calcium;phosphane Chemical compound P.[Ca] MWKXCSMICWVRGW-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 229960001031 glucose Drugs 0.000 description 3
- 230000005802 health problem Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000037081 physical activity Effects 0.000 description 3
- 235000002949 phytic acid Nutrition 0.000 description 3
- 239000000467 phytic acid Substances 0.000 description 3
- 229940068041 phytic acid Drugs 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010006956 Calcium deficiency Diseases 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- ZQBZAOZWBKABNC-UHFFFAOYSA-N [P].[Ca] Chemical compound [P].[Ca] ZQBZAOZWBKABNC-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000004097 bone metabolism Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000011812 mixed powder Substances 0.000 description 2
- 230000010016 myocardial function Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000011164 ossification Effects 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 206010006002 Bone pain Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 239000004470 DL Methionine Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 208000005475 Vascular calcification Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001615 biotins Chemical class 0.000 description 1
- 238000005422 blasting Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000000326 densiometry Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 239000011833 salt mixture Substances 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 229930193551 sterin Natural products 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940010250 vitamin k 2 Drugs 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses health food containing vitamin K2. The health food is composed of the following components in percentage by weight: 0.02-0.1% of the vitamin K2, 0.01-0.1% of biotin, 10-32% of milk mineral salt, 2-10% of casein phosphopeptide, 1-8% of probiotics, 8-28% of whey protein powder, 9-22% of a pueraria extract and the balance being auxiliary materials. According to the food, natural components such as high-quality vitamin, protein, and probiotics are compounded to interact in an intestinal tract, so that the intestinal tract and the blood environment are perfected, the action of the vitamin K2 is promoted and the content of blood calcium is adjusted together with the vitamin K2. The health food is scientific and reasonable in composition, natural in ingredients, appropriate in proportion, reliable in efficacy and convenient to eat.
Description
Technical field
The present invention relates to changing the dietetic product of food nutrition property, especially one kind contains vitamin k2Health care food
Product.
Background technology
It is known that in human body, 99% calcium is stored in skeleton, in tooth and fingernail.1% calcium is present in blood and tissue
In.Skeleton is equivalent to the calcium storehouse of human body, and the calcium deposited is more stable.Calcium in blood and tissue is calcium pond, Main Function: nerve
Conduction and muscle contraction.Phosphorus is the constituent of ribosomal ribonucleic acid (dna), and phospholipid is composition necessary to all cell membrane, and phosphorus is also joined
Catabolism with fat and fatty acid.In addition, every 2 grams of calcium need 1 gram of phosphorus in the forming process of bone, put down with reaching calcium phosphorus
Weighing apparatus.It is not difficult that the mankind get enough phosphorus from food, has phosphorus in substantially any food, but takes purification when people is substantial amounts of
When calcium, phosphorus can be extracted the two-to-one ecological relationship of synthesis by these calcium, and calcium phosphorus balance then can be broken, and assume phospholipid and lack
Mistake state.And more than 40 kind of disease of human body is all relevant with calcium disorder.
At present, on market, the health food of " increase bone density " is broadly divided into two classes: a class is the health food of calcic, is
Reach increase bone density purpose by direct supplement calcium, this kind of health food mainly passes through vitamin d3To promote the suction of calcium
Receive, absorb and excessively easily cause the health problems such as calcium disorder, muscle bone pain, and calcium involve in too high, lead to calcium phosphorus ration
Unbalance, thus leading to a series of sclerotin and intestinal absorption problem;Another kind of be free from calcium or not with replenish the calcium for purpose health care food
Product, are to promote the absorption of calcium thus reaching increase bone density this purpose, such as soybean isoflavone, sulphuric acid by adjusting endocrine
Chrondroitin.This kind of health food is mainly inherent regulation, but calcium Deficiency of Intake is equally problem, and has certain side effect, example
As stimulated gastric mucosa, cause constipation etc..Therefore, invent a kind of regulating intestinal canal flora, alleviate calcium disorder and then improve osteoporosises
Health food particularly important.
Content of the invention
In order to overcome deficiency of the prior art, a kind of composition of present invention offer is scientific and reasonable, composition is natural, proportioning is proper
When, taking convenience is containing vitamin k2Health food.
The technical solution adopted for the present invention to solve the technical problems is: one kind contains vitamin k2Health food, it is special
Levy and be: it comprises the following components in percentage by weight: vitamin k20.02~0.1%, biotin 0.01~0.1%, Ru Kuang
Thing salt 10~32%, phosphopeptide caseinate 2~10%, probiotic bacteria 1~8%, lactalbumin powder 8~28%, Radix Puerariae extract 9~22%,
Remaining is adjuvant, and the percentage by weight sum of each component is 100%.
Further, probiotic bacteria be by one of bacillus acidophilus, bacillus bifiduss, Lactobacillus plantarum or more than one.
Further, described adjuvant is made up of starch and Microcrystalline Cellulose, wherein, the percentage by weight of described starch
For 6~25%, the percentage by weight of described Microcrystalline Cellulose is 6~25%.
The precedence technique scheme of the present invention is: the percentage by weight of described each component is: vitamin k20.06%th, biotin
0.04%th, newborn mineral salt 26%, phosphopeptide caseinate 3%, probiotic bacteria 6%, lactalbumin powder 21%, Radix Puerariae extract 16%, adjuvant
27.9%, wherein, in described adjuvant, the percentage by weight of starch is 12.5%, and the percentage by weight of Microcrystalline Cellulose is 15.4%.
The present invention containing vitamin k2Health food, can be made into health-caring capsule, by capsule body and being encapsulated in capsule body
Content composition, through dispensing, mixing, filling, polishing, select and the operation such as pick and make capsule, producing content content is
The health-caring capsule of the supplementary several mineral materials of 300mg~600mg/ grain.The concrete preparation technology of its capsule belongs to prior art, no
Repeat again.
Usage of the present invention and consumption are: the daily recommended amounts of adult are 1.2g.Pressing human body recommended intake is that 2 times a day, often
Secondary 2, can long-term taking.
The present invention is the natural components such as high-quality vitamin, protein, probiotic bacteria, and wherein, effect of each component is as follows: dimension life
Plain k2Be to maintain the necessary nutrient of normal physiological function in human body, calcium played with the effect that management controls, control bone and
Calcium metabolism, it is ensured that calcium effective mineralising deposition and holding on skeleton of absorption, eliminates osteoporosises, hyperosteogeny;Biotin
Also known as w factor, the decomposition of fat and carbohydrate can be promoted, make them accelerate to change into the energy needed for physical activity,
Help improve the regulation of blood glucose, biotin and vitamin k by improving the use of insulin and blood glucose2Collocation, function can be made
Strengthening, effectively prevents calcium, the loss of phosphorus and burn fat;Puerarin in Radix Puerariae extract has certain to external bone formation
Facilitation, can improve bone mineral content, bone mineral density and bone biomechanical intensity, and puerarin causes external and estrogen simultaneously
Action character be consistent, also blood pressure lowering, improve cerebral circulation and myocardial function;Newborn mineral salt is a kind of new resource food, due to
There is the calcium-phosphorus ratio close with human body it is considered to be outstanding raw material of replenishing the calcium;Phosphopeptide caseinate (cpp) ph in human body intestinal canal
In neutral in weakly alkaline environment, calcium, ferrum, zinc ion can be chelated, protect it from by the phosphoric acid in meals, oxalic acid, phytic acid etc.
Anion precipitates, and effectively facilitates the absorption to calcium, ferrum, zinc etc. and utilization;Lactalbumin purity is high, absorbance is high, Amino acid group
Become the most reasonable, high-purity lactalbumin is in human body and vitamin k2In conjunction with can effectively strengthen bone strength, adjust blood calcium dense
Degree is so as to reach normal level;Probiotic bacteria can help digest in vivo, absorb, the various nutrient of metabolism, such as: protein, sugar,
Fiber, trace element etc., can be effectively improved intestinal environment, promote the antibacterial in people's intestinal to be directly synthesized vitamin k2, for human body
Absorb.Also can synthesize nutrient, the application conversion of cholesterol and lipid metabolism simultaneously, purify gastroenteric environment, protection liver,
The heart, kidney etc..The present invention has compounded the natural components such as high-quality vitamin, protein, probiotic bacteria, can interact in intestinal,
Improve intestinal and blood environment, promote the absorption of vitamin and other nutrients.Wherein, cpp(phosphopeptide caseinate) addition
Calcium, phosphorus, zinc ion being chelated, protecting it from being precipitated by aniones such as the phosphoric acid in meals, oxalic acid, phytic acid, thus effectively facilitating
Absorption to calcium, phosphorus, zinc etc. and utilization, cpp, except promoting the absorption of calcium, can also promote the absorption of mineral, and
Obviate the excessive injury to intestines and stomach of vitamin d;Biotin and vitamin k2Collocation, can make function intensified, both permissible
Effectively prevent the loss of calcium, phosphorus, again can be with burn fat;High-purity lactalbumin is in human body and vitamin k2In conjunction with can have
Effect strengthens bone strength, adjusts blood calcium concentration so as to reach normal level;Probiotic bacteria can assist synthetic vitamin in intestinal
k2, promote vitamin k2Effect, work in coordination with its adjust blood calcium.The each component of the present invention is worked in coordination with it and is adjusted blood calcium, has and changes
A series of health problems such as kind osteoporosises, regulating intestinal canal flora, alleviation calcium disorder.Compared with prior art, present invention composition
Scientific and reasonable, composition is natural, proportioning is appropriate, taking convenience.
Specific embodiment
With reference to embodiments of the invention, the present invention is described further.
Raw materials used in the present embodiment be commercial products, wherein,
Vitamin k2Emerging purchased from Henan sky, its content is >=99%;This vitamin k2It is in human body, to maintain normal physiology work(
The necessary nutrient of energy, plays the effect that management controls to calcium, controls bone and calcium metabolism it is ensured that the calcium taken in has on skeleton
Effect mineralising deposition and holding, eliminate osteoporosises, hyperosteogeny;Vitamin k first2Prepare bigger space for calcium, catch
More calcium, increase bone mass and bone density;Next allow calcium to crystallize more regular, increase bone strength;Vitamin k2Also remove blood
Pipe calcium speckle, elimination hyperosteogeny, therefore play management and control effect to abnormal calcium metabolism.Vitamin k2Superpower calcium management function is right
Respond well in treatment of vascular calcification, hyperosteogeny, thus reaching the purpose of protection cardiovascular and cerebrovascular vessel.
Biotin is purchased from upper seashore magnesium, and its content is >=99%;This biotin, also known as w factor, can promote fat and carbon water
The decomposition of compound, makes them accelerate to change into the energy needed for physical activity, is helped by improving insulin and using of blood glucose
Help the regulation improving blood glucose, biotin and vitamin k2Collocation, can make function intensified, effectively prevent calcium, the loss of phosphorus and combustion
Burn fat;And biotin can promote the decomposition of fat and carbohydrate, them are made to accelerate to change into the energy needed for physical activity
Amount.
Newborn mineral salt is derived from New Zealand's import, wherein content >=25% of calcium;Content >=13% of phosphorus;This newborn mineral salt is one
Kind of new resource food, due to having the calcium-phosphorus ratio close with human body it is considered to be outstanding raw material of replenishing the calcium.Calcium and the pass of calitriol
System, under normal circumstances, our human body can be automatically synthesized calitriol by sunlight, in order to decompose in our every daily ingestion foods
Calcareous, and the calcium taking purification of our excess, the one wrong instruction of our automatic-balancing system will be given, internal,
Blood, body fluid not calcium deficiency, then, the instruction producing calitriol is closed, and the calcium absorbing cannot get calitriol and can only run off,
Just not saying it has also upset the normal operation of phosphorus.
Phosphopeptide caseinate can be given birth to purchased from Jiangxi, and its content is >=99%;This phosphopeptide caseinate (cpp) is in human body intestinal canal
Interior ph in weakly alkaline environment, can chelate calcium, ferrum, zinc ion, protect it from by the phosphoric acid in meals, oxalic acid, plant in neutral
The aniones such as acid precipitate, and effectively facilitate the absorption to calcium, ferrum, zinc etc. and utilization.
Probiotic bacteria is purchased from Shanghai promise Shen, wherein lactic acid bacteria sum/(cfu/g) >=5 × 107, bacillus bifiduss/(cfu/g) >=
2.5×107, bacillus acidophilus/(cfu/g) >=2.5 × 107, Lactobacillus plantarum/(cfu/g) >=2.5 × 107;Probiotic bacteria is in body
Interior help digest, absorb, the various nutrient of metabolism, such as: protein, sugar, fiber, trace element etc., intestinal can be effectively improved
Environment, promotes the antibacterial in people's intestinal to be directly synthesized vitamin k2, utilize for absorption of human body.Also nutrient, gallbladder can be synthesized simultaneously
The application conversion of sterin and lipid metabolism, purify gastroenteric environment, protection liver, the heart, kidney etc..
Lactalbumin powder is derived from imported from America, and its protein content is >=90%;This lactalbumin be using advanced technologies from
Milk separation and Extraction precious protein out, forms the many advantages quilt such as the most reasonable with its purity height, absorbance height, aminoacid
Push away as " king of albumen ".High-purity lactalbumin is in human body and vitamin k2In conjunction with can effectively strengthen bone strength, adjust blood
Calcium concentration is so as to reach normal level.
Radix Puerariae extract is purchased from Hanzhong sky Rangu, and its puerarin content is >=60%.Puerarin in Radix Puerariae extract is to body
Outer bone formation has certain facilitation, can improve bone mineral content, bone mineral density and bone biomechanical intensity, Radix Puerariae simultaneously
Element is caused and is consistent with the action character of estrogen in vitro, also blood pressure lowering, improve cerebral circulation and myocardial function.
The present invention has compounded the natural components such as high-quality vitamin, protein, probiotic bacteria, can interact, change in intestinal
Kind intestinal and blood environment, promote the absorption of vitamin and other nutrients.Wherein, cpp(phosphopeptide caseinate) addition energy
Chelating calcium, phosphorus, zinc ion, protect it from being precipitated by aniones such as the phosphoric acid in meals, oxalic acid, phytic acid, thus effectively facilitate right
The absorption of calcium, phosphorus, zinc etc. and utilization.Cpp, except promoting the absorption of calcium, can also promote the absorption of mineral, and get rid of
Except the excessive injury to intestines and stomach of vitamin d.Biotin and vitamin k2Collocation, can make function intensified, both can have
Effect prevents the loss of calcium, phosphorus, again can be with burn fat, and high-purity lactalbumin is in human body and vitamin k2In conjunction with can be effective
Strengthen bone strength, adjust blood calcium concentration so as to reach normal level.Probiotic bacteria can assist synthetic vitamin k in intestinal2,
Promote vitamin k2Effect, work in coordination with its adjust blood calcium.The each component of the present invention is worked in coordination with it and is adjusted blood calcium, has improvement
A series of health problems such as osteoporosises, regulating intestinal canal flora, alleviation calcium disorder.
Embodiment 1
One kind contains vitamin k2Health food, it comprises the following components in percentage by weight: vitamin k20.06%th, raw
Thing element 0.04%, newborn mineral salt 26%, phosphopeptide caseinate 3%, probiotic bacteria 6%, lactalbumin powder 21%, Radix Puerariae extract 16%, auxiliary
Material 27.9%, wherein, in adjuvant, the percentage by weight of starch is 12.5%, and the percentage by weight of Microcrystalline Cellulose is 15.4%.This reality
Apply that example provided containing vitamin k2Health food composition scientific and reasonable, composition is natural, proportioning is appropriate, taking convenience.
Embodiment 2
One kind contains vitamin k2Health food, it comprises the following components in percentage by weight: vitamin k20.02%th, raw
Thing element 0.1%, newborn mineral salt 32%, phosphopeptide caseinate 2%, bacillus acidophilus 3%, bacillus bifiduss 3%, Lactobacillus plantarum 2%, milk surum
Egg albumen powder 8%, Radix Puerariae extract 18.88%, adjuvant 31%, wherein, starch 6%, Microcrystalline Cellulose 25% in adjuvant.The present embodiment institute
There is provided containing vitamin k2Health food composition scientific and reasonable, composition is natural, proportioning is appropriate, taking convenience.
Embodiment 3
One kind contains vitamin k2Health food, it comprises the following components in percentage by weight: vitamin k20.1%th, raw
Thing element 0.01%, newborn mineral salt 10%, phosphopeptide caseinate 7.89%, bacillus acidophilus 1%, lactalbumin powder 28%, Radix Puerariae extract
22%th, adjuvant 31%, wherein, starch 25%, Microcrystalline Cellulose 6% in adjuvant.The present embodiment provided containing vitamin k2Health care
Food composition is scientific and reasonable, composition is natural, proportioning is appropriate, taking convenience.
Embodiment 4
One kind contains vitamin k2Health food, it comprises the following components in percentage by weight: vitamin k20.05%th, raw
Thing element 0.05%, newborn mineral salt 25.9%, phosphopeptide caseinate 10%, bacillus acidophilus 2.5%, bacillus bifiduss 2.5%, lactalbumin
Powder 25%, Radix Puerariae extract 9%, adjuvant 25%, wherein, starch 15%, Microcrystalline Cellulose 10% in adjuvant.The present embodiment is provided
Containing vitamin k2Health food composition scientific and reasonable, composition is natural, proportioning is appropriate, taking convenience.
Finished product involved by the embodiment of the present invention 1~4, can be prepared into capsule by following process steps:
A () dispensing weighs according to percentage by weight: vitamin k 2, biotin, newborn mineral salt, phosphopeptide caseinate, prebiotic
Bacterium, lactalbumin powder, Radix Puerariae extract, starch, Microcrystalline Cellulose, proceed in 300,000 grades of clean areas, and cross 80 mesh sieves respectively, standby
With;
B vitamin k that step (a) is weighed by () mixing2, biotin, newborn mineral salt, phosphopeptide caseinate, probiotic bacteria,
Lactalbumin powder, Radix Puerariae extract, starch, Microcrystalline Cellulose send into blender by the way of stirring while in mixing, stirring is mixed
It is bonded to pink colour pool consistent, no color differnece, obtain mixed powder;
C the mixed powder that step (b) obtains is sent into Autocapsulefillingmachine and is packed in capsule shells by () filling, obtain guarantor
Strong capsule;
D health-caring capsule that step (c) is obtained by () polishing is inserted and is processed by shot blasting in buffing machine so as to capsule shows
Bright and clean;
E () choosing picks the choosing of the health-caring capsule after being polished step (d) and picks unless eurymeric ball, obtain eurymeric health-caring capsule;
(f) packaging, finished product: the eurymeric health-caring capsule obtained by step (e) is carried out bottling, encapsulates, finished product.
Below to contain vitamin k given by embodiment 12Health food carry out zoopery, further illustrate this
Bright have the effects such as improve osteoporosises, regulating intestinal canal flora, alleviate calcium disorder.
1) material and method
1.1) sample: the capsule produced according to embodiment 1 is sample.
1.2) dosage group selection and tested material give mode: low calcium feed formula (gram): casein 10.0, analysis for soybean powder
15.0, wheat flour 54.0, Oleum Arachidis hypogaeae semen 4.0, cellulose 2.0, ain-76 salt-mixture 2.6, ain-76 mixed vitamin 1.0, chlorination
Choline 0.2, dl- Methionine 0.2, starch 11.0, add caco3 to make feedstuff calcium content reach 150mg/100g, raise as low calcium
Material.
According to human oral's recommended amounts, the sample of the present invention is that basic, normal, high dosage is respectively 0.25g/kg.bw, 0.50g/
Kg.bw, 1.50g/kg.bw(are respectively equivalent to 5 times, 10 times, 30 times that human body recommends consumption), when Calcium Carbonate reference substance is prepared,
The Calcium Carbonate (being equivalent to the high dose of the present invention) of basic, normal, high dosage.When preparing sample, basic, normal, high dosage takes respectively
2.50g, 5.00g, 15.00g add deionized water to 100ml, and calcium carbonate control group takes 5.97g Calcium Carbonate to add deionized water extremely
100ml, low calcium matched group gives isopyknic deionized water, gives animal subject gavage respectively, daily gavage once, gavage body
Amass as 11.0ml/100g.bw.
1.3) experimental situation condition: experimental situation is barrier environment.22 DEG C~24 DEG C of ambient temperature, humidity 52%~58%.
1.4) key instrument: sd-1000c bone mineral measuring instrument.
1.5) experimental technique:
Growth and development index: weigh in weekly and height.
Femur-bone densitometry: at the end of experiment, sacrificed by decapitation rat, peel off right femur, permanent through baking in 105 baking boxs
Weight, after being cooled to room temperature, measures the length of femur and the bone density of midpoint and distal end.
Calcium content of bone measures: uses edta titration measuring after the gross weight weighing femur.
Functional component, physical and chemical index, sanitary index: according to enterprise-quality standard test.
2) experimental result
2.1) Data Processing in Experiment: carry out data conversion and statistical analysiss with spss11.0 software.
2.2) interpretation of result: give the calcium content of bone of tested material group or bone density be significantly higher than low calcium matched group, and with phase
It is not significantly different from compared with dosage calcium carbonate control group, the absorbance of calcium is not less than calcium carbonate control group, can determine that tested material
There is the effect increasing bone density;Its functional component index, physical and chemical index, Hygienic Index all meet company standard q/
The regulation of rch007-2009d.
The impact to rat body weight for table 1 sample
As shown in Table 1, experimental group rat initial with mid-term body weight compared with low calcium matched group no significant difference (p >
0.05);Calcium carbonate control group and high dose group rat latter stage body weight and weightening there were significant differences compared with low calcium matched group (p <
0.01), the initial weight of high dose group experimental group rat.Mid-term weight, latter stage weight and its have a net increase of value added compared with calcium carbonate control group not
There is marked difference (p > 0.05).
The impact to rat height for table 2 sample
As shown in Table 2, initial and mid-term height no significant difference (p > compared with low calcium matched group of each experimental group rat
0.05);Calcium carbonate control group and high calcium dosage group rat latter stage height and its have compared with having a net increase of the value added matched group with low calcium notable
Difference (p < 0.01), high dose experimental group rat starves initial height, mid-term height, length and height have a net increase of value added Calcium Carbonate all the life
Matched group is compared and is not significantly different from (p > 0.05).
The impact to rat femur length and bone density for table 3 sample
As can be seen from Table 3, the femur length of high dose group rat, femur center bone density, femur distal end bone density
Compared with corresponding calcium carbonate control group, it is not significantly different from (p > 0.05);Calcium carbonate control group, high calcium dosage group femur are long
Degree is noticeably greater than low calcium matched group (p < 0.01);Calcium carbonate control group, middle dose group, high dose group rat femur center bone are close
Degree is noticeably greater than low calcium matched group (p < 0.01).Calcium carbonate control group and high dose group rat femur distal end bone density are notable
More than low calcium matched group (p < 0.01).
The femur weight of table 4 sample high dose group rat, the impact of femur calcium content
As can be seen from Table 4, the femur weight of sample high dose group rat, the impact of femur calcium content.High dose is tested
The femur weight of group rat, femur calcium content and calcium total amount, compared with corresponding calcium carbonate control group, are not significantly different from (p >
0.05);Calcium carbonate control group, high calcium dosage group femur weight are noticeably greater than low calcium matched group (p < 0.01);Calcium Carbonate compares
Group, middle dose group, high dose group rat femur TC and calcium content are noticeably greater than low calcium matched group (p < 0.01).
Show through animal test results, having enhancing using the capsule of the technique preparation given by the present invention increases bone density
Function.
Claims (3)
1. one kind contains vitamin k2Health food it is characterised in that: it comprises the following components in percentage by weight: vitamin
k20.02~0.1%, biotin 0.01~0.1%, newborn mineral salt 10~32%, phosphopeptide caseinate 2~10%, probiotic bacteria 1~8%,
Lactalbumin powder 8~28%, Radix Puerariae extract 9~22%, remaining is adjuvant;Described adjuvant is by starch and Microcrystalline Cellulose group
Become, wherein, the percentage by weight of described starch is 6~25%, and the percentage by weight of described Microcrystalline Cellulose is 6~25%;
The percentage by weight sum of each component is 100%.
2. one kind according to claim 1 contains vitamin k2Health food it is characterised in that: the weight of described each component
Percentage ratio is: vitamin k20.06%th, biotin 0.04%, newborn mineral salt 26%, phosphopeptide caseinate 3%, probiotic bacteria 6%, milk surum egg
White lead 21%, Radix Puerariae extract 16%, adjuvant 27.9%, wherein, in described adjuvant, the percentage by weight of starch is 12.5%, crystallite
The percentage by weight of cellulose is 15.4%.
3. one kind according to claim 1 and 2 contains vitamin k2Health food it is characterised in that: described probiotic bacteria is
By one of bacillus acidophilus, Bifidobacterium lactis, Lactobacillus plantarum or more than one.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410801527.4A CN104432099B (en) | 2014-12-22 | 2014-12-22 | Health food containing vitamin K2 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410801527.4A CN104432099B (en) | 2014-12-22 | 2014-12-22 | Health food containing vitamin K2 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104432099A CN104432099A (en) | 2015-03-25 |
CN104432099B true CN104432099B (en) | 2017-02-01 |
Family
ID=52879446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410801527.4A Active CN104432099B (en) | 2014-12-22 | 2014-12-22 | Health food containing vitamin K2 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104432099B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110122863A (en) * | 2019-05-31 | 2019-08-16 | 广东双骏生物科技有限公司 | A kind of special medicine purposes food and preparation method thereof improving liver function |
CN113115954A (en) * | 2019-12-31 | 2021-07-16 | 北京司晨扬帆国际管理咨询有限公司 | Calcium vitamin D3Vitamin K2Health food and its preparation method |
CN111616232A (en) * | 2020-06-12 | 2020-09-04 | 北安宜品努卡乳业有限公司 | Children milk powder for promoting bone growth and preparation method thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101537170B (en) * | 2008-03-17 | 2012-05-30 | 哈药集团制药六厂 | Compound for preventing osteoporosis and osteoarthrosis |
CN102356877A (en) * | 2011-10-14 | 2012-02-22 | 李泼 | CBP calcium supplement electuary |
CN102813202A (en) * | 2012-09-06 | 2012-12-12 | 苏州谷力生物科技有限公司 | Health-care product for preventing osteoporosis |
CN103039976A (en) * | 2012-12-05 | 2013-04-17 | 无锡市天赐康生物科技有限公司 | Healthcare food for increasing bone density and preparation method thereof |
CN103142641B (en) * | 2013-03-11 | 2015-05-20 | 昆明邦宇制药有限公司 | Calcium carbonate-vitamin K pharmaceutical preparation and preparation method thereof |
CN103142640A (en) * | 2013-04-01 | 2013-06-12 | 李拖平 | Health care product containing vitamin K2 and having functions of preventing and treating brittle-bone disease |
CN103653170B (en) * | 2013-11-21 | 2015-06-10 | 威海百合生物技术股份有限公司 | Stachyose probiotics solid beverage |
-
2014
- 2014-12-22 CN CN201410801527.4A patent/CN104432099B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN104432099A (en) | 2015-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101720939B (en) | Giant salamander meat and bone meal capsules, preparation method and application thereof | |
CN102356798B (en) | Milk calcium candy and preparation method thereof | |
CN101268835B (en) | Nutrition high calcium medicinal granule for children and preparing technique | |
CN102356877A (en) | CBP calcium supplement electuary | |
CN102415447B (en) | Calcium supplement electuary for infants and preparation process thereof | |
CN102524548A (en) | Compound premixed feeds for cattle and sheep health protection and preparation method thereof | |
CN103271274A (en) | Nutrient health-care porridge | |
CN109329848A (en) | A kind of sesame ball formula and preparation method containing xylo-oligosaccharide | |
CN107494963B (en) | Calcium paste for pets and preparation method thereof | |
CN104432099B (en) | Health food containing vitamin K2 | |
CN101279089B (en) | Donkey-hide gelatin calcium composition and preparing process thereof | |
CN105076417A (en) | Intestine protective formula milk powder and preparation method thereof | |
CN109170916A (en) | One kind keeps fit and healthy food compositions and preparation method thereof | |
CN105533450A (en) | Nutritional health-care rice flour and preparation method thereof | |
CN101803695B (en) | Calcium and iron supplement product being applicable to children | |
CN105053213A (en) | Milk powder capable of improving infant's immunity and production method thereof | |
CN103622090A (en) | Novel paste capable of strengthening kidney and enhancing physical strength | |
CN104187095B (en) | Pig feed during a kind of molasses are compound | |
CN107136490A (en) | A kind of peptide Chinese caterpillar fungus health product | |
CN106937746A (en) | Selenium adds calcium soft capsule and preparation method | |
CN109452491A (en) | One hatching egg feed additive for fowls and preparation method thereof | |
CN104013853B (en) | A kind of composition of strong kidney kidney tonifying and preparation method thereof | |
CN102273669A (en) | Spirulina amino acid tablet | |
TWM579033U (en) | Protein and peptide containing microparticle structure | |
CN102150837A (en) | Formula of ferroheme peptide chewable tablets and making method of ferroheme peptide chewable tablets |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |